The anti-obesity drug industry was in 2023 valued at $5.6 billion and will exhibit a CAGR of 27% between 2024 and 2032 (expert opinion).
$LLY+0.2%, $NVO+0.0% and others are creating drugs like - Ozempic, Wegovy, Mounjaro and Zepbound - These are blockbusters in terms of weight loss market in my opinion. But which companies may have the best chance to take the biggest bite of...
Read more
For me ro are both great companies. I wouldn't be afraid to include them in my portfolio. At what price would you buy $LLY+0.2%?